Clinical Trial Update: Effect of OC459 on the Response to Rhinovirus Challenge in Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating OC459 on response to rhinovirus challenge in individuals with asthma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinovirus Infection

Drugs mentioned

• OC459

Snippet

Sponsor: Imperial College London | Conditions: Asthma, Rhinovirus | Phase 2 | Status: COMPLETED | Results posted: 2021-02-26